While p53 regulates many oncogenic processes both through its TF activity as well as transcription-independent mechanisms [113–115], TP53 mutations are understood to promote cancer primarily by disrupting TF activity, since virtually all disrupt DNA binding [87, 116]. Here, TF is linked to cancer.